Cart summary

You have no items in your shopping cart.

Ginsenoside F4 (Standard)

SKU: orb3139077

Description

Ginsenoside F4 (Standard) is a reference standard for research and analysis in studies involving Ginsenoside F4. Ginsenoside F4 exerts inhibitory effects on human lymphocytoma JK cells by inducing apoptosis. The mechanism of action involves mitochondrial dysfunction, increased Bax expression, and reduced Bcl-2 expression, together resulting in programmed cell death.

Images & Validation

Key Properties

CAS Number181225-33-2
MW767.01
FormulaC42H70O12
SMILESC[C@]12[C@@]3(C)[C@@]([C@@H](\C(=C\CC=C(C)C)\C)CC3)([C@H](O)C[C@@]1([C@]4(C)[C@@]([C@@H](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O)[C@@H](CO)O5)C2)(C(C)(C)[C@@H](O)CC4)[H])[H])[H]
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Ginsenoside F4 (Standard) (orb3139077)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%